Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 29% ± 5% | |
glutamatergic neuron | 3 studies | 35% ± 8% | |
astrocyte | 3 studies | 19% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 27% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 634.18 | 459 / 459 | 100% | 16.56 | 1118 / 1118 |
esophagus | 100% | 663.51 | 1445 / 1445 | 100% | 11.58 | 183 / 183 |
skin | 100% | 1478.48 | 1809 / 1809 | 100% | 20.37 | 472 / 472 |
thymus | 100% | 873.15 | 653 / 653 | 100% | 14.23 | 605 / 605 |
uterus | 100% | 681.94 | 170 / 170 | 100% | 12.85 | 459 / 459 |
lung | 100% | 723.45 | 578 / 578 | 100% | 9.95 | 1154 / 1155 |
intestine | 100% | 603.35 | 966 / 966 | 100% | 8.75 | 526 / 527 |
bladder | 100% | 631.57 | 21 / 21 | 99% | 9.18 | 501 / 504 |
prostate | 100% | 643.27 | 245 / 245 | 99% | 7.40 | 499 / 502 |
ovary | 100% | 521.63 | 180 / 180 | 99% | 9.88 | 427 / 430 |
pancreas | 99% | 499.23 | 326 / 328 | 99% | 7.43 | 177 / 178 |
stomach | 100% | 488.04 | 358 / 359 | 99% | 9.53 | 283 / 286 |
kidney | 100% | 479.58 | 89 / 89 | 98% | 13.80 | 887 / 901 |
adrenal gland | 100% | 644.07 | 257 / 258 | 98% | 7.54 | 225 / 230 |
liver | 99% | 328.74 | 224 / 226 | 96% | 6.35 | 389 / 406 |
brain | 92% | 297.12 | 2424 / 2642 | 100% | 10.33 | 705 / 705 |
adipose | 100% | 641.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 708.49 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.25 | 29 / 29 |
spleen | 100% | 740.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.19 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.79 | 1 / 1 |
muscle | 99% | 344.17 | 798 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 11.06 | 79 / 80 |
heart | 95% | 337.07 | 821 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 89% | 978.57 | 828 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0042276 | Biological process | error-prone translesion synthesis |
GO_0009314 | Biological process | response to radiation |
GO_0010225 | Biological process | response to UV-C |
GO_0006282 | Biological process | regulation of DNA repair |
GO_0006290 | Biological process | pyrimidine dimer repair |
GO_0006260 | Biological process | DNA replication |
GO_0071494 | Biological process | cellular response to UV-C |
GO_0070987 | Biological process | error-free translesion synthesis |
GO_0000731 | Biological process | DNA synthesis involved in DNA repair |
GO_0005657 | Cellular component | replication fork |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0035861 | Cellular component | site of double-strand break |
GO_0005634 | Cellular component | nucleus |
GO_0003887 | Molecular function | DNA-directed DNA polymerase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0003684 | Molecular function | damaged DNA binding |
Gene name | POLH |
Protein name | DNA polymerase eta DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein) Truncated DNA polymerase eta DNA polymerase eta transcript variant |
Synonyms | XPV RAD30 RAD30A |
Description | FUNCTION: DNA polymerase specifically involved in the DNA repair by translesion synthesis (TLS) . Due to low processivity on both damaged and normal DNA, cooperates with the heterotetrameric (REV3L, REV7, POLD2 and POLD3) POLZ complex for complete bypass of DNA lesions. Inserts one or 2 nucleotide(s) opposite the lesion, the primer is further extended by the tetrameric POLZ complex. In the case of 1,2-intrastrand d(GpG)-cisplatin cross-link, inserts dCTP opposite the 3' guanine . Particularly important for the repair of UV-induced pyrimidine dimers . Although inserts the correct base, may cause base transitions and transversions depending upon the context. May play a role in hypermutation at immunoglobulin genes . Forms a Schiff base with 5'-deoxyribose phosphate at abasic sites, but does not have any lyase activity, preventing the release of the 5'-deoxyribose phosphate (5'-dRP) residue. This covalent trapping of the enzyme by the 5'-dRP residue inhibits its DNA synthetic activity during base excision repair, thereby avoiding high incidence of mutagenesis . Targets POLI to replication foci . . |
Accessions | A0A977TKC9 ENST00000372226.1 [Q9Y253-2] C4P9N5 Q9Y253 ENST00000372236.9 [Q9Y253-1] ENST00000443535.1 Q5JTF2 |